Kim JB et al describieron un caso de colitis isqumica en una mujer de 39 aos, sin antecedentes mdicos de inters, tras la combinacin de mesoterapia y frmacos antiobesidad
External resources New England Journal of Medicine: Tirzepatide versus semaglutide in type 2 diabetes (SURPASS-2 trial) PMC: Switching between GLP-1 receptor agonists, rationale and practical guidance Endocrine Practice: Switching to tirzepatide from GLP-1 receptor agonists, clinical expectations PMC: The risk of vestibular disorders with semaglutide and tirzepatide In case I do not see you, good afternoon, good evening, and good night
Belperio, Carl Atkinson The complement system has emerged as a critical regulator of intestinal homeostasis, inflammation, and cancer
No national generalities just the rules, plans, and options that apply to you in 2026